HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Parasitic Liver Diseases

Subscribe to New Research on Parasitic Liver Diseases

Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).

Also Known As:

Liver Diseases, Parasitic; Disease, Parasitic Liver; Diseases, Parasitic Liver; Liver Disease, Parasitic; Parasitic Liver Disease

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Infection

Experts

1.	Soares, Kevin C: 1 article (02/2014)
2.	Pawlik, Timothy M: 1 article (02/2014)
3.	Herman, Joseph M: 1 article (02/2014)
4.	Kamel, Ihab: 1 article (02/2014)
5.	Cosgrove, David P: 1 article (02/2014)
6.	Tanaka, H: 1 article (10/2010)
7.	Ioka, A: 1 article (10/2010)
8.	Tsukuma, H: 1 article (10/2010)
9.	Nakahara, T: 1 article (10/2010)
10.	Tanaka, M: 1 article (10/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Parasitic Liver Diseases:

1.	Primary sclerosing cholangitisIBA 02/01/2014 - "A variety of risk factors have been associated with HC, most notably primary sclerosing cholangitis (PSC), biliary stone disease and parasitic liver disease. " 10/01/2010 - "There are several established risk factors for intrahepatic cholangiocarcinoma (ICC), namely primary sclerosing cholangitis, fibropolycystic liver disease, parasitic infection, intrahepatic biliary stones and chemical carcinogen exposure. "
2.	Phospholipases (Phospholipase)IBA 01/01/1985 - "[Phospholipase activity, lipid peroxides and antioxidants of the bile in parasitic liver diseases]."
3.	Lipid PeroxidesIBA 01/01/1985 - "[Phospholipase activity, lipid peroxides and antioxidants of the bile in parasitic liver diseases]."
4.	Antipyrine (Phenazone)FDA Link 10/01/1979 - "1. Drug-metabolizing capacity in cases of polycystic non-parasitic liver disease was investigated using plasma antipyrine clearance as an index. "
5.	AntioxidantsIBA 01/01/1985 - "[Phospholipase activity, lipid peroxides and antioxidants of the bile in parasitic liver diseases]."
6.	Alveolar echinococcosisIBA 09/01/1994 - "Alveolar echinococcosis (AE), an uncommon and very severe parasitic liver disease, can be considered as an "infectious model" of granulomatous disease, where cellular immunity plays a key role in the defence against Echinococcus multilocularis, the larval cestode responsible for the disease. "
7.	Intrahepatic cholangiocarcinomaIBA 10/01/2010 - "There are several established risk factors for intrahepatic cholangiocarcinoma (ICC), namely primary sclerosing cholangitis, fibropolycystic liver disease, parasitic infection, intrahepatic biliary stones and chemical carcinogen exposure. "